Cambio to expand operations in Sri Lanka

Cambio Healthcare Systems, a leading Scandinavian supplier of e-health solutions, announced that its CEO, Rami Avidan, CFO, Johannes Fabó and COO, Arash Noujoumi will be visiting the company’s Sri Lankan office, Cambio Software Engineering PTE LTD, based in Colombo.

This visit comes at a time when Sri Lanka is facing economic challenges. However, the company remains committed to Sri Lanka and plans to further expand its operation here through a massive recruitment drive aimed at increasing its employee base in Sri Lanka. 

The main focus of their trip will be to hold discussions with the Sri Lanka Leadership Team in order to outline their vision for the future of product development. This will include exploring the potential for new products, services, and technologies that can be introduced to the market in the near future. In addition to this, the Senior Leadership Team will be meeting with some of the key universities in the country, in order to build partnerships and explore collaboration opportunities.

Finally, the Senior Leadership Team will be meeting with senior government officials in the IT industry in order to discuss ways to promote the growth of the software industry in Sri Lanka. This will include exploring the potential for government support and investment in the sector, and identifying any barriers or challenges that need to be overcome in order to drive growth and development.

CEO of Cambio Healthcare Systems Rami Avidan said, “Sri Lanka has established itself as an innovative development center in the tech industry and we are committed to supporting the growth of this sector and providing opportunities for local talent to thrive.” Cambio Software Engineering is a fully owned subsidiary of Cambio Healthcare Systems AB, headquartered in Stockholm, Sweden.

A leading provider of innovative enterprise healthcare solutions in Europe, Cambio has over 700 employees in its offices in Sweden, the UK, Denmark, and Sri Lanka.

 

Tuesday, February 14, 2023 – 01:00











Comments (0)
Add Comment